Koers Immune Pharmaceuticals, Inc.
Aandelen
FZRQ
US45254C2008
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 37 | 12-04-21 | |
Devin J. Shaw
DFI | Director of Finance/CFO | 37 | 13-04-21 |
John Zhang
CTO | Chief Tech/Sci/R&D Officer | - | 11-12-17 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
David Sidransky
BRD | Director/Board Member | 64 | - |
Tony Fiorino
BRD | Director/Board Member | 56 | 15-08-17 |
John A. Neczesny
BRD | Director/Board Member | 60 | 02-02-16 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+26,08% | 662 mld. | |
+21,85% | 546 mld. | |
-4,77% | 359 mld. | |
+16,97% | 323 mld. | |
+5,69% | 290 mld. | |
+13,68% | 234 mld. | |
+3,65% | 198 mld. | |
-11,12% | 194 mld. | |
-3,40% | 157 mld. |